Mind the magnesium, in dantrolene suppression of malignant hyperthermia
- PMID: 28442565
- PMCID: PMC5422787
- DOI: 10.1073/pnas.1704103114
Mind the magnesium, in dantrolene suppression of malignant hyperthermia
Conflict of interest statement
The author declares no conflict of interest.
Comment on
-
Dantrolene requires Mg2+ to arrest malignant hyperthermia.Proc Natl Acad Sci U S A. 2017 May 2;114(18):4811-4815. doi: 10.1073/pnas.1619835114. Epub 2017 Apr 3. Proc Natl Acad Sci U S A. 2017. PMID: 28373535 Free PMC article.
References
-
- Loke J, MacLennan DH. Malignant hyperthermia and central core disease: Disorders of Ca2+ release channels. Am J Med. 1998;104:470–486. - PubMed
-
- Kolb ME, Horne ML, Martz R. Dantrolene in human malignant hyperthermia. Anesthesiology. 1982;56:254–262. - PubMed
-
- Fruen BR, Mickelson JR, Louis CF. Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. J Biol Chem. 1997;272:26965–26971. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
